Top compounds associated with response to LRRC47


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.012 0.7
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.012 0.7
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA IOX2 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.013 0.7
mRNA austocystin d CTRPv2 pan-cancer AAC 0.013 0.7
mRNA tivozanib GDSC1000 pan-cancer AAC 0.011 0.7
Download CSV